Innovative Industrial Properties, Inc.

What they do

IIP acquires, owns and manages specialized industrial and commercial properties in the United States, primarily leasing them to experienced, state-licensed operators for regulated cannabis facilities. Acquisitions are generally done through sale-leaseback transactions and third-party purchases, with leases typically structured as triple-net, where the tenant covers structural repairs, maintenance, real estate taxes and insurance. As of December 31, 2025, the company owned 111 properties totaling 8.9 million rentable square feet across 19 states, with 23 full-time employees.

Revenue drivers

• Cannabis facility leases (operating portfolio) — Rental income from 109 operating properties that were 96.7% leased as of December 31, 2025, with a weighted-average remaining lease term of 12.8 years; this is the overwhelming majority of the portfolio.
• Life science investments — Financial investments in the life science industry, including the IQHQ revolving credit facility investment and IQHQ Preferred Stock, which the company intends to grow as a key component of its strategy.
• Properties under development/redevelopment — Two properties excluded from the operating portfolio as of December 31, 2025 (Inland Center Drive in San Bernardino, California and Leah Avenue in San Marcos, Texas), together expected to comprise 255,000 rentable square feet upon completion.

Recent performance

Annual revenue declined from $309.5 million in 2023 to $308.5 million in 2024 and $266.0 million in 2025, with net income falling from $165.6 million in 2023 to $161.7 million in 2024 and $118.2 million in 2025. Diluted EPS followed the same path, at $5.77 in 2023, $5.52 in 2024 and $3.93 in 2025, while operating cash flow dropped from $258.4 million in 2024 to $198.2 million in 2025. Quarterly revenue was $64.7 million in Q3 2025, $66.7 million in Q4 2025, $69.0 million in Q1 2026 and $63.3 million in Q2 2026. As of June 30, 2026, total assets were $2.58 billion, total liabilities $730.0 million and shareholder equity $1.85 billion, with $204.7 million of cash and equivalents.

Strategy

Management states that market dynamics in regulated cannabis have been extremely challenging, citing federal, state and local taxation burdens, ineffective enforcement against the illicit market, declining unit pricing, limited access to capital, and inflation and supply chain constraints. Because these conditions have hurt certain tenants' ability to pay rent, the company has expanded its growth strategy to include a broader range of real estate and real estate-related investments, adding life science as a targeted sector. It also indicates it may pursue joint ventures, debt or mezzanine financing, preferred or joint venture equity interests, and interests in other real estate funds or REITs. During 2025 the company acquired one new property and made additional investments into existing properties under development or redevelopment, ending the year with $6.5 million committed to fund tenant and vendor improvement draws.

Risks

• Tenant defaults and re-leasing — Industry conditions have already negatively impacted certain tenants' ability to make lease payments, and the company may be unable to re-lease properties at current rents, or at all, upon default or termination.
• Concentration of portfolio and tenants — The portfolio and tenant base are concentrated, so the loss or distress of a limited number of cannabis tenants would have an outsized effect on rental revenue.
• Life science investment exposure — The company has real estate-related investments in IQHQ, including the IQHQ credit facility and IQHQ preferred stock, and defaults on those investments would directly affect results.
• Federal cannabis illegality and regulatory uncertainty — Cannabis remains illegal under federal law, and the timing, scope and impact of the April 2026 DOJ and DEA final order on federal scheduling status of certain marijuana activities are uncertain.

Outlook

Management characterizes regulated cannabis market dynamics as extremely challenging and attributes recent revenue and earnings declines to those conditions and their effect on tenants. It intends to broaden the investment mandate beyond cannabis into life science and other real estate-related assets. The company also flags the timing and scope of the April 2026 DOJ/DEA order on federal marijuana scheduling as an unresolved factor, and states it expects to continue acquiring cannabis properties through sale-leasebacks and third-party purchases.